{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:06:09Z","timestamp":1757628369433,"version":"3.44.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-025-01683-6","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:44:41Z","timestamp":1757414681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a gastric cancer prognostic model utilizing lymphatic endothelial cell-related genes"],"prefix":"10.1186","volume":"20","author":[{"given":"Sijie","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"1683_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN Es- timates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209\u201349.","journal-title":"Cancer J Clin"},{"key":"1683_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.20566","volume":"94","author":"F Roviello","year":"2006","unstructured":"Roviello F, Rossi S, Marrelli D, Pedrazzani C, Corso G, Vindigni C, et al. Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol. 2006;94:275\u201380. discussion 274.","journal-title":"J Surg Oncol"},{"key":"1683_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","volume":"121","author":"R Kim","year":"2007","unstructured":"Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007;121:1\u201314.","journal-title":"Immunology"},{"key":"1683_CR4","doi-asserted-by":"publisher","first-page":"e9863","DOI":"10.1371\/journal.pone.0009863","volume":"5","author":"CC Clement","year":"2010","unstructured":"Clement CC, Cannizzo ES, Nastke MD, Sahu R, Olszewski W, Miller NE, et al. An expanded self-antigen peptidome is carried by the human lymph as compared to the plasma. PLoS ONE. 2010;5:e9863.","journal-title":"PLoS ONE"},{"key":"1683_CR5","unstructured":"Podgrabinska S, Kamalu O, Mayer L, Shimaoka M, Snoeck H, Randolph GJ et al. Inflamed lymphatic endothelium sup-."},{"key":"1683_CR6","doi-asserted-by":"crossref","unstructured":"presses dendritic cell maturation and function via Mac-1\/ICAM- 1-dependent mechanism. Journal of Immunology. 2009;183: 1767\u20131779.","DOI":"10.4049\/jimmunol.0802167"},{"key":"1683_CR7","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.4049\/jimmunol.1302492","volume":"192","author":"S Hirosue","year":"2014","unstructured":"Hirosue S, Vokali E, Raghavan VR, Rincon-Restrepo M, Lund AW, Corth\u00e9sy-Henrioud P, et al. Steady-state antigen scaveng- ing, cross-presentation, and CD8\u2009+\u2009T cell priming: a new role for lymphatic endothelial cells. J Immunol. 2014;192:5002\u201311.","journal-title":"J Immunol"},{"key":"1683_CR8","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/bjc.2015.282","volume":"113","author":"MW Tokumoto","year":"2015","unstructured":"Tokumoto MW, Tanaka H, Tauchi Y, Kasashima H, Kurata K, Yashiro M, et al. Identification of tumour-reactive lymphatic en- dothelial cells capable of inducing progression of gastric cancer. Br J Cancer. 2015;113:1046\u201354.","journal-title":"Br J Cancer"},{"key":"1683_CR9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/cas.12977","volume":"107","author":"Y Tauchi","year":"2016","unstructured":"Tauchi Y, Tanaka H, Kumamoto K, Tokumoto M, Sakimura C, Sakurai K, et al. Tumor-associated macrophages induce capil- lary morphogenesis of lymphatic endothelial cells derived from human gastric cancer. Cancer Sci. 2016;107:1101\u20139.","journal-title":"Cancer Sci"},{"key":"1683_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/vhrm.2006.2.2.97","volume":"2","author":"RWC Pang","year":"2006","unstructured":"Pang RWC, Poon RTP. Clinical implications of angiogenesis in cancers. Vasc Health Risk Manag. 2006;2:97\u2013108.","journal-title":"Vasc Health Risk Manag"},{"key":"1683_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RYJ, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166:21\u201345.","journal-title":"Cell"},{"key":"1683_CR12","doi-asserted-by":"publisher","first-page":"vii89","DOI":"10.1093\/annonc\/mdq292","volume":"21","author":"P Savagner","year":"2010","unstructured":"Savagner P. The epithelial-mesenchymal transition (EMT) phe- nomenon. Ann Oncol. 2010;21:vii89\u201392.","journal-title":"Ann Oncol"},{"key":"1683_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2016.07.037","volume":"381","author":"XY Mao","year":"2016","unstructured":"Mao XY, Li QQ, Gao YF, Zhou HH, Liu ZQ, Jin WL. Gap junc- Tion as an intercellular glue: emerging roles in cancer EMT and metastasis. Cancer Lett. 2016;381:133\u20137.","journal-title":"Cancer Lett"},{"key":"1683_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.","journal-title":"Genome Biol"},{"key":"1683_CR15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41419-022-04838-1","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Liu F, Yang Y, Yu N, Weng X, Yang Y, et al. Inte- grated DNA and RNA sequencing reveals early drivers involved in metastasis of gastric cancer. Cell Death Dis. 2022;13:392.","journal-title":"Cell Death Dis"},{"key":"1683_CR16","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge- based approach for interpreting genome-wide expression pro- files. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1683_CR17","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41598-018-37909-5","volume":"9","author":"E Katsuta","year":"2019","unstructured":"Katsuta E, Qi Q, Peng X, Hochwald SN, Yan L, Takabe K. Pan- creatic adenocarcinomas with mature blood vessels have better overall survival. Sci Rep. 2019;9:1310.","journal-title":"Sci Rep"},{"key":"1683_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00441-003-0745-x","volume":"314","author":"H Gerhardt","year":"2003","unstructured":"Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in an- giogenesis. Cell Tissue Res. 2003;314:15\u201323.","journal-title":"Cell Tissue Res"},{"key":"1683_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/bcr573","volume":"5","author":"JL Yu","year":"2003","unstructured":"Yu JL, Rak JW. Host microenvironment in breast cancer devel- opment: inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res. 2003;5:83\u20138.","journal-title":"Breast Cancer Res"},{"key":"1683_CR20","first-page":"2875","volume":"37","author":"M Tokumoto","year":"2017","unstructured":"Tokumoto M, Tanaka H, Tauchi Y, Tamura T, Toyokawa T, Kimura K, et al. Immunoregulatory function of lymphatic En- dothelial cells in Tumor-draining lymph nodes of human Gas- tric Cancer. Anticancer Res. 2017;37:2875\u201383.","journal-title":"Anticancer Res"},{"key":"1683_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.5483\/BMBRep.2021.54.8.054","volume":"54","author":"J Moon","year":"2021","unstructured":"Moon J, Oh YM, Ha SJ. Perspectives on immune checkpoint ligands: expression, regulation, and clinical implications. BMB Rep. 2021;54:403\u201312.","journal-title":"BMB Rep"},{"key":"1683_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/cac2.12278","volume":"42","author":"XD Zhu","year":"2022","unstructured":"Zhu XD, Huang MZ, Wang YS, Feng WJ, Chen ZY, He YF, et al. XELOX doublet regimen versus EOX triplet regimen as first- line treatment for advanced gastric cancer: an open-labeled, multicenter, randomized, prospective phase III trial (EXELOX). Cancer Commun. 2022;42:314\u201326.","journal-title":"Cancer Commun"},{"key":"1683_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0092-8674(91)90642-C","volume":"64","author":"LA Liotta","year":"1991","unstructured":"Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regu- lation. Cell. 1991;64:327\u201336.","journal-title":"Cell"},{"key":"1683_CR24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/01.RES.0000182903.16652.d7","volume":"97","author":"A Armulik","year":"2005","unstructured":"Armulik A, Abramsson A, Betsholtz C. Endothelial\/pericyte in- teractions. Circul Res. 2005;97:512\u201323.","journal-title":"Circul Res"},{"key":"1683_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pag\u00e8s F, Saut\u00e8s-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Na- Ture Reviews Cancer. 2012;12:298\u2013306.","journal-title":"Na- Ture Reviews Cancer"},{"key":"1683_CR26","unstructured":"Deng G. Tumor-infiltrating regulatory T cells: origins and features. Am J Clin Exp Immunol. 2018;7(5):81\u20137."},{"key":"1683_CR27","first-page":"1080","volume":"18","author":"ers for immunotherapy","year":"2021","unstructured":"ers for immunotherapy. Outcomes across multiple solid tumor types. Cancer Biology Med. 2021;18:1080\u201391.","journal-title":"Cancer Biology Med"},{"key":"1683_CR28","first-page":"81","volume":"7","author":"G Deng","year":"2018","unstructured":"Deng G. Tumor-infiltrating regulatory T cells: origins and fea- Tures. Am J Clin Experimental Immunol- Ogy. 2018;7:81\u20137.","journal-title":"Am J Clin Experimental Immunol- Ogy"},{"key":"1683_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-021-01056-8","volume":"14","author":"JA Marin-Acevedo","year":"2021","unstructured":"Marin-Acevedo JA, Kimbrough EO, Lou Y. Next generation of immune checkpoint inhibitors and beyond. J Hematol- Ogy Oncol. 2021;14:45.","journal-title":"J Hematol- Ogy Oncol"},{"key":"1683_CR30","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0092-8674(00)81402-6","volume":"92","author":"S Soker","year":"1998","unstructured":"Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92:735\u201345.","journal-title":"Cell"},{"key":"1683_CR31","doi-asserted-by":"publisher","first-page":"25520","DOI":"10.1074\/jbc.M102315200","volume":"276","author":"GB Whitaker","year":"2001","unstructured":"Whitaker GB, Limberg BJ, Rosenbaum JS. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor com- plex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). J Biol Chem. 2001;276:25520\u201331.","journal-title":"J Biol Chem"},{"key":"1683_CR32","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1096\/fj.00-0250com","volume":"14","author":"HQ Miao","year":"2000","unstructured":"Miao HQ, Lee P, Lin H, Soker S, Klagsbrun M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and pro- Gression. FASEB J. 2000;14:2532\u20139.","journal-title":"FASEB J"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01683-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01683-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01683-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:55:11Z","timestamp":1757487311000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01683-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1683"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01683-6","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Commit- tee of Fudan University Shanghai Cancer Center (Approval No.: 050432-4-1805\u00a0C). All experiments were performed in accordance with relevant guidelines and regulations such as the Declaration of Helsinki and the patients signed the informed consent form and agreed to be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}